Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL) in the United States and worldwide, accounting for about 22 percent of newly diagnosed …

Diffuse Large B-Cell Lymphoma iffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin lympho a (NHL). It accounts for approximately 1 in 3 new cases of B-cell NHL …

Diffuse Large B-Cell Lymphoma: Relapsed/Refractory most common form of non-Hodgkin lymphoma (NHL), accounting for about 1 out of spleen, liver, and bone marrow (the spongy …

Patients interested in participating in a clinical trial should view the Understanding Clinical Trials fact sheet on the Foundation’s website (visit lymphoma.org/publications), and the Clinical …

Treatment Options Since DLBCL can advance quickly, it usually requires immediate treatment. A combination of chemotherapy and the monoclonal antibody rituximab (Rituxan), with or without …

Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type: This lymphoma usually appears as solitary or multiple tumor nodules on the legs, arms, and/or torso and is less common but …

Patients with lymphoma should have regular visits with a physician who is familiar with their medical history and the treatments they have received. Medical tests (such as blood tests and …

High-dose chemotherapy followed by stem cell transplantation can be used to treat patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma.

HGBL, not otherwise specified (NOS). This subtype includes aggressive B-cell lymphomas with mixed characteristics of other types of B-cell lymphoma such as DLBCL, Burkitt lymphoma …

With respect to gene mutations, HGBCL shares many features with two other types of B-cell lymphomas—diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma.